Merck Taps Google Cloud for AI Transformation

By: Editorial Team

April 22, 2026


  • Companies: Merck (MRK), Google Cloud
  • Location: Global (announced Las Vegas)
  • Deal value: Up to $1B multi-year
  • Focus area: Agentic AI across operations
  • Next steps: Deploy Gemini to 75,000 employees

What happened?

Merck announced a landmark partnership with Google Cloud on 22 April 2026 to build an AI-enabled digital backbone across its operations. The multi-year collaboration, valued at up to $1 billion, will deploy Google Cloud’s Gemini Enterprise platform throughout research & development, manufacturing, commercial and corporate functions.

Why does it matter?

The deal positions Merck for its largest product launch period, using agentic AI to accelerate scientific innovation, optimise manufacturing via predictive analytics and personalise patient engagement. With pharma R&D costs exceeding $2.5B per asset, AI-driven productivity for 75,000 employees could compress timelines and improve decision-making across the value chain.

Who’s behind it?

Merck (NYSE: MRK, MSD outside US/Canada) brings scientific leadership; Google Cloud provides AI infrastructure and engineers working directly with Merck teams. Builds on prior collaborations, targeting end-to-end workflows from drug discovery to commercial operations.

How was it achieved?

Google Cloud engineers will embed with Merck to implement Gemini across R&D (scientific workflows), manufacturing (predictive maintenance), commercial (data-driven insights) and corporate functions (automation). The agentic platform digitises data and integrates generative AI tools for scalable impact.

What’s next?

Rollout begins immediately, scaling AI adoption company-wide to support major launches. Expect productivity gains, faster breakthroughs and competitive advantage as Merck enters “next era of biopharmaceutical growth”.

What are people saying?

Dave Williams, Merck CIO: “Next phase of our AI journey… reimagine processes at scale and bring breakthroughs to patients faster.” Thomas Kurian, Google Cloud CEO: “Fundamental shift in how technology supports the entire pharma value chain.”

More News From:

/